Stay updated on Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial
Sign up to get notified when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.

Latest updates to the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a minor update to the page’s rendering or metadata. This change does not alter study data or content, but reflects an incremental improvement to the site itself.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a new revision of the study details page. This appears to be a minor metadata update rather than a substantive change to content or features.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision metadata updated from v3.6.3 to v3.6.4, indicating a newer release of the page content.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision label in the Study Documents section was updated from v3.6.2 to v3.6.3, indicating a new document revision.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page shows a new revision tag, changing from v3.6.0 to v3.6.2. This indicates a minor update to the page without altering the study details.SummaryDifference0.0%

- Check92 days agoChange DetectedNew navigation items were added (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study). The Intervention label was standardized from 'Intervention / Treatment' to 'Intervention/Treatment', the revision tag updated to v3.6.0, and a recruitment note indicates no more participants are being sought.SummaryDifference0.3%

Stay in the know with updates to Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.